Mark A. Velleca, President and CEO at G1 Therapeutics, Inc. (GTHX), sold 30,000 shares at $19.97 ($586K) on 2020-12-17, disclosed to the SEC on 2020-12-17.
Open-market sale of $586k GTHX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.43 | 10,000 | $194K | 33.2% |
| 2 | $19.20 | 10,000 | $192K | 32.8% |
| 3 | $19.97 | 10,000 | $200K | 34.1% |
| Total | $19.53 avg | 30,000 | $586K | 100% |
| Filing → |
| GTHX | SELL | 2022-09-22 | $270K | — | Filing → |
| GTHX | SELL | 2022-08-18 | $1.0M | — | Filing → |
| GTHX | SELL | 2021-07-15 | $946K | — | Filing → |